Blueprint Medicines Corp (BPMC)

109.68 +0.65 (+0.60%) USD  |  NASDAQ  |  Jul 05, 12:35
More

Blueprint Medicines EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for BPMC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS LT Growth Estimates Data

View and export this data back to 2021. Upgrade now.
Date Value
June 17, 2021 --

EPS LT Growth Estimates Range, Past 5 Years

Upgrade
Minimum
Jun 17 2021
Upgrade
Maximum
Jun 17 2021
Upgrade
Average
Upgrade
Median
Jun 17 2021

EPS LT Growth Estimates Benchmarks

Ligand Pharmaceuticals Inc Upgrade
Biomarin Pharmaceutical Inc Upgrade
Apellis Pharmaceuticals Inc --
Alnylam Pharmaceuticals Inc --
Cytokinetics Inc Upgrade